The DOI matches its Crossref record; 79 of the 79 references it cites were found in a registry or an index.
Caspofungin
Abstract
Caspofungin, the first inhibitor of fungal beta-1,3 glucan synthesis to receive approval by the United States Food and Drug Administration, is effective for the treatment of mucosal and invasive candidiasis and invasive aspergillosis. It is also active in vitro and in animal models against a number of other filamentous and dimorphic endemic fungi and in animal models of Pneumocystis carinii infection. In vitro studies and some animal studies almost always indicate an absence of antagonism when caspofungin is combined with azole or polyene antifungal agents. Caspofungin has an excellent safety profile. Caspofungin may prove to be useful in empirical therapy for suspected invasive fungal infections. Additional clinical trial data that expand our knowledge of the usefulness of caspofungin for these and other mycoses, including its administration in combination with other antifungal agents, is anticipated. Caspofungin is an important addition to the antifungal pharmacopoeia.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Comparison of Caspofungin and Amphotericin B for Invasive Candidiasis
Mora-Duarte, J., Betts, R., Rotstein, C., Colombo, A. L., Thompson-Moya, L., Smietana, J., Lupinacci, R., Sable, C., Kartsonis, N., & Perfect, J. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa021585 · Cited by 1,380
Kuhn, D. M., George, T., Chandra, J., Mukherjee, P. K., & Ghannoum, M. A. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.6.1773-1780.2002 · Cited by 764
Cell Wall and Secreted Proteins of Candida albicans: Identification, Function, and Expression
Chaffin, W. L., López-Ribot, J. L., Casanova, M., Gozalbo, D., & Martínez, J. P. (1998) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.62.1.130-180.1998 · Cited by 726
Espinel-Ingroff, A. (1998) · Journal of Clinical Microbiology · doi:10.1128/jcm.36.10.2950-2956.1998 · Cited by 576
Identification of Yeast Rho1p GTPase as a Regulatory Subunit of 1,3-β-Glucan Synthase
Qadota, H., Python, C. P., Inoue, S. B., Arisawa, M., Anraku, Y., Zheng, Y., Watanabe, T., Levin, D. E., & Ohya, Y. (1996) · Science · doi:10.1126/science.272.5259.279 · Cited by 445
Molecular Organization of the Alkali-insoluble Fraction ofAspergillus fumigatus Cell Wall
Fontaine, T., Simenel, C., Dubreucq, G., Adam, O., Delepierre, M., Lemoine, J., Vorgias, C. E., Diaquin, M., & Latgé, J.-P. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m909975199 · Cited by 436
Differential Expression and Function of Two Homologous Subunits of Yeast 1,3-β-D-Glucan Synthase
Mazur, P., Morin, N., Baginsky, W., el-Sherbeini, M., Clemas, J. A., Nielsen, J. B., & Foor, F. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.10.5671 · Cited by 424
The Yeast Cell Wall and Septum as Paradigms of Cell Growth and Morphogenesis
Cabib, E., Roh, D.-H., Schmidt, M., Crotti, L. B., & Varma, A. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.r000031200 · Cited by 343
Discovery of Novel Antifungal (1,3)-β- d -Glucan Synthase Inhibitors
Onishi, J., Meinz, M., Thompson, J., Curotto, J., Dreikorn, S., Rosenbach, M., Douglas, C., Abruzzo, G., Flattery, A., Kong, L., et al. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.2.368-377.2000 · Cited by 326
Kurtz, M. B., Heath, I. B., Marrinan, J., Dreikorn, S., Onishi, J., & Douglas, C. (1994) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.38.7.1480 · Cited by 320
Fungal ß(1,3)-D-glucan synthesis
Douglas, C. M. (2001) · Medical Mycology · doi:10.1080/mmy.39.1.55.66 · Cited by 312
In vitro preclinical evaluation studies with the echinocandin antifungal MK-0991 (L-743,872)
Bartizal, K., Gill, C. J., Abruzzo, G. K., Flattery, A. M., Kong, L., Scott, P. M., Smith, J. G., Leighton, C. E., Bouffard, A., Dropinski, J. F., et al. (1997) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.41.11.2326 · Cited by 311
Villanueva, A., Arathoon, E. G., Gotuzzo, E., Berman, R. S., DiNubile, M. J., & Sable, C. A. (2001) · Clinical Infectious Diseases · doi:10.1086/323401 · Cited by 308
Bowman, J. C., Hicks, P. S., Kurtz, M. B., Rosen, H., Schmatz, D. M., Liberator, P. A., & Douglas, C. M. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.9.3001-3012.2002 · Cited by 303
Villanueva, A., Gotuzzo, E., Arathoon, E. G., Noriega, L. M., Kartsonis, N. A., Lupinacci, R. J., Smietana, J. M., DiNubile, M. J., & Sable, C. A. (2002) · The American Journal of Medicine · doi:10.1016/s0002-9343(02)01191-9 · Cited by 292
In Vitro Activity of Caspofungin against Candida albicans Biofilms
Bachmann, S. P., VandeWalle, K., Ramage, G., Patterson, T. F., Wickes, B. L., Graybill, J. R., & López-Ribot, J. L. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.11.3591-3596.2002 · Cited by 288
Kirkpatrick, W. R., Perea, S., Coco, B. J., & Patterson, T. F. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.8.2564-2568.2002 · Cited by 282
Aspergillus fumigatus cell wall: composition and biosynthesis
Bernard, M., & Latgé, J.-P. (2001) · Medical Mycology · doi:10.1080/mmy.39.1.9.17 · Cited by 282
In Vitro Synergy of Caspofungin and Amphotericin B against Aspergillus and Fusarium spp
Arikan, S., Lozano-Chiu, M., Paetznick, V., & Rex, J. H. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.1.245-247.2002 · Cited by 280
The pathobiology of Paracoccidioides brasiliensis
Borges-Walmsley, M. I., Chen, D., Shu, X., & Walmsley, A. R. (2002) · Trends in Microbiology · doi:10.1016/s0966-842x(01)02292-2 · Cited by 272
Arathoon, E. G., Gotuzzo, E., Noriega, L. M., Berman, R. S., DiNubile, M. J., & Sable, C. A. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.2.451-457.2002 · Cited by 254
Single- and Multiple-Dose Pharmacokinetics of Caspofungin in Healthy Men
Stone, J. A., Holland, S. D., Wickersham, P. J., Sterrett, A., Schwartz, M., Bonfiglio, C., Hesney, M., Winchell, G. A., Deutsch, P. J., Greenberg, H., et al. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.3.739-745.2002 · Cited by 246
Ramage, G., VandeWalle, K., Bachmann, S. P., Wickes, B. L., & López-Ribot, J. L. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.11.3634-3636.2002 · Cited by 244
Abruzzo, G. K., Flattery, A. M., Gill, C. J., Kong, L., Smith, J. G., Pikounis, V. B., Balkovec, J. M., Bouffard, A. F., Dropinski, J. F., Rosen, H., et al. (1997) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.41.11.2333 · Cited by 241
Pfaller, M. A., Marco, F., Messer, S. A., & Jones, R. N. (1998) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/s0732-8893(97)00246-0 · Cited by 241
van Duin, D., Casadevall, A., & Nosanchuk, J. D. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.11.3394-3400.2002 · Cited by 232
Aliff, T. B., Maslak, P. G., Jurcic, J. G., Heaney, M. L., Cathcart, K. N., Sepkowitz, K. A., & Weiss, M. A. (2003) · Cancer · doi:10.1002/cncr.11115 · Cited by 227
Lipopeptide inhibitors of fungal glucan synthase
Kurtz, M. B., & Douglas, C. M. (1997) · Medical Mycology · doi:10.1080/02681219780000961 · Cited by 216
Quality Control Limits for Broth Microdilution Susceptibility Tests of Ten Antifungal Agents
Barry, A. L., Pfaller, M. A., Brown, S. D., Espinel-Ingroff, A., Ghannoum, M. A., Knapp, C., Rennie, R. P., Rex, J. H., & Rinaldi, M. G. (2000) · Journal of Clinical Microbiology · doi:10.1128/jcm.38.9.3457-3459.2000 · Cited by 211
Glucan Synthase Complex of Aspergillus fumigatus
Beauvais, A., Bruneau, J. M., Mol, P. C., Buitrago, M. J., Legrand, R., & Latgé, J. P. (2001) · Journal of Bacteriology · doi:10.1128/jb.183.7.2273-2279.2001 · Cited by 209
Bowman, J. C., Abruzzo, G. K., Anderson, J. W., Flattery, A. M., Gill, C. J., Pikounis, V. B., Schmatz, D. M., Liberator, P. A., & Douglas, C. M. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.12.3474-3481.2001 · Cited by 208
Shematek, E. M., Braatz, J. A., & Cabib, E. (1980) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)86116-1 · Cited by 202
In Vitro Susceptibility Testing Methods for Caspofungin against Aspergillus and Fusarium Isolates
Arikan, S., Lozano-Chiu, M., Paetznick, V., & Rex, J. H. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.1.327-330.2001 · Cited by 202
Thompson, J. R., Douglas, C. M., Li, W., Jue, C. K., Pramanik, B., Yuan, X., Rude, T. H., Toffaletti, D. L., Perfect, J. R., & Kurtz, M. (1999) · Journal of Bacteriology · doi:10.1128/jb.181.2.444-453.1999 · Cited by 196
Perea, S., Gonzalez, G., Fothergill, A. W., Kirkpatrick, W. R., Rinaldi, M. G., & Patterson, T. F. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.9.3039-3041.2002 · Cited by 186
Petraitiene, R., Petraitis, V., Groll, A. H., Sein, T., Schaufele, R. L., Francesconi, A., Bacher, J., Avila, N. A., & Walsh, T. J. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.1.12-23.2002 · Cited by 182
Ernst, E. J., Klepser, M. E., & Pfaller, M. A. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.4.1108-1111.2000 · Cited by 181
Abruzzo, G. K., Gill, C. J., Flattery, A. M., Kong, L., Leighton, C., Smith, J. G., Pikounis, V. B., Bartizal, K., & Rosen, H. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.9.2310-2318.2000 · Cited by 171
Del Poeta, M., Cruz, M. C., Cardenas, M. E., Perfect, J. R., & Heitman, J. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.3.739-746.2000 · Cited by 169
Preliminary animal pharmacokinetics of the parenteral antifungal agent MK-0991 (L-743,872)
Hajdu, R., Thompson, R., Sundelof, J. G., Pelak, B. A., Bouffard, F. A., Dropinski, J. F., & Kropp, H. (1997) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.41.11.2339 · Cited by 165
Del Poeta, M., Schell, W. A., & Perfect, J. R. (1997) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.41.8.1835 · Cited by 164
In vitro pharmacodynamic properties of MK-0991 determined by time-kill methods
Ernst, E. J., Klepser, M. E., Ernst, M. E., Messer, S. A., & Pfaller, M. A. (1999) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/s0732-8893(98)00130-8 · Cited by 158
Pfaller, M. A., Diekema, D. J., Messer, S. A., Hollis, R. J., & Jones, R. N. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.3.1068-1071.2003 · Cited by 152
Update on antifungals targeted to the cell wall: focus on β-1,3-glucan synthase inhibitors
Georgopapadakou, N. H. (2001) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.10.2.269 · Cited by 149
Safety and tolerability of caspofungin acetate in the treatment of fungal infections
Sable, C. A., Nguyen, B. T., Chodakewitz, J. A., & DiNubile, M. J. (2002) · Transplant Infectious Disease · doi:10.1034/j.1399-3062.2002.01004.x · Cited by 148
Feldmesser, M., Kress, Y., Mednick, A. J., & Casadevall, A. (2000) · The Journal of Infectious Diseases · doi:10.1086/317614 · Cited by 134
Powles, M. A., Liberator, P., Anderson, J. W., Karkhanis, Y. D., Dropinski, J. F., Bouffard, F. A., Balkovec, J. M., Fujioka, H., Aikawa, M., McFadden, D. C., et al. (1998) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.42.8.1985 · Cited by 130
Caspofungin: An echinocandin antifungal agent
Stone, E. A., Fung, H. B., & Kirschenbaum, H. L. (2002) · Clinical Therapeutics · doi:10.1016/s0149-2918(02)85039-1 · Cited by 126
Franzot, S. P., & Casadevall, A. (1997) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.41.2.331 · Cited by 122
Bachmann, S. P., Patterson, T. F., & Lopez-Ribot, J. L. (2002) · Journal of Clinical Microbiology · doi:10.1128/jcm.40.6.2228-2230.2002 · Cited by 120
Vázquez, J. A., Lynch, M., Boikov, D. A., & Sobel, J. D. (1997) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.41.7.1612 · Cited by 118
Cell-wall glucans of Cryptococcus neoformans CAP 67
James, P. G., Cherniak, R., Jones, R. G., Stortz, C. A., & Reiss, E. (1990) · Carbohydrate Research · doi:10.1016/0008-6215(90)84273-w · Cited by 116
Kontoyiannis, D. P., Lewis, R. E., Osherov, N., Albert, N. D., & May, G. S. (2003) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkg090 · Cited by 116
Kelly, R., Register, E., Hsu, M. J., Kurtz, M., & NIELSEN, J. B. K. (1996) · Journal of Bacteriology · doi:10.1128/jb.178.15.4381-4391.1996 · Cited by 114
The Candida albicans Cdr2p ATP‐binding cassette (ABC) transporter confers resistance to caspofungin
Schuetzer‐Muehlbauer, M., Willinger, B., Krapf, G., Enzinger, S., Presterl, E., & Kuchler, K. (2003) · Molecular Microbiology · doi:10.1046/j.1365-2958.2003.03430.x · Cited by 112
Marco, F., Pfaller, M. A., Messer, S. A., & Jones, R. N. (1998) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/s0732-8893(98)00050-9 · Cited by 107
Metabolites of Caspofungin Acetate, a Potent Antifungal Agent, in Human Plasma and Urine
Balani, S. K., Xu, X., Arison, B. H., da Silva, M. V. M., Gries, A., Deluna, F. A., Cui, D., Kari, P. H., Ly, T., Hop, C. E. C. A., et al. (2000) · Drug Metabolism and Disposition · doi:10.1016/s0090-9556(24)15072-6 · Cited by 104
Roling, E. E., Klepser, M. E., Wasson, A., Lewis, R. E., Ernst, E. J., & Pfaller, M. A. (2002) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/s0732-8893(02)00361-9 · Cited by 100
Kohler, S., Wheat, L. J., Connolly, P., Schnizlein-Bick, C. T., Durkin, M., Smedema, M. L., Goldberg, J. S., & Brizendine, E. J. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.7.1850-1854.2000 · Cited by 99
Breakthrough Trichosporonosis in a Bone Marrow Transplant Recipient Receiving Caspofungin Acetate
Goodman, D., Pamer, E. G., Jakubowski, A. A., Morris, C. D., & Sepkowitz, K. A. (2002) · Clinical Infectious Diseases · doi:10.1086/341305 · Cited by 92
Composition and Structure of Yeast Cell Walls
Fleet, G. H. (1985) · Current topics in medical mycology · doi:10.1007/978-1-4613-9547-8_2 · Cited by 87
Membrane and cell wall targets in Aspergillus fumigatus
Beauvais, A., & Latgé, J.-P. (2001) · Drug Resistance Updates · doi:10.1054/drup.2001.0185 · Cited by 84
González, G. M., Tijerina, R., Najvar, L. K., Bocanegra, R. A., Luther, M. F., Rinaldi, M. G., & Graybill, J. R. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.6.1854-1859.2001 · Cited by 78
Efficacy of Caspofungin in the Treatment of Esophageal Candidiasis Resistant to Fluconazole
Kartsonis, N., DiNubile, M. J., Bartizal, K., Hicks, P. S., Ryan, D., & Sable, C. A. (2002) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/00126334-200210010-00009 · Cited by 77
Barchiesi, F., Schimizzi, A. M., Fothergill, A. W., Scalise, G., & Rinaldi, M. G. (1999) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/pl00015011 · Cited by 74
Glucan synthase inhibitors as antifungal agents
Kurtz, M. B., & Rex, J. H. (2001) · Advances in protein chemistry · doi:10.1016/s0065-3233(01)56011-8 · Cited by 73
Manavathu, E. K. (2003) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkg242 · Cited by 73
Treatment of Histoplasmosis with MK-991 (L-743,872)
Graybill, J. R., Najvar, L. K., Montalbo, E. M., Barchiesi, F., Luther, M. F., & Rinaldi, M. G. (1998) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.42.1.151 · Cited by 70
Shalit, I., Shadkchan, Y., Samra, Z., & Osherov, N. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.4.1416-1418.2003 · Cited by 68
Treatment of murine Candida krusei or Candida glabrata infection with L-743,872
Graybill, J. R., Bocanegra, R. A., Luther, M., Fothergill, A. W., & Rinaldi, M. J. (1997) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.41.9.1937 · Cited by 68
Treatment of murine disseminated candidiasis with L-743,872
Graybill, J. R., Najvar, L. K., Luther, M. F., & Fothergill, A. W. (1997) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.41.8.1775 · Cited by 67
Calcineurin-dependent growth of an FK506- and CsA-hypersensitive mutant of Saccharomyces cerevisiae
Parent, S. A., NIELSEN, J. B. K., Morin, N. R., Chrebet, G. L., Ramadan, N., Dahl, A. M., Hsu, M. J., Bostian, K. A., & Foor, F. (1993) · Journal of General Microbiology · doi:10.1099/00221287-139-12-2973 · Cited by 62
Semisynthetic echinocandins affect cell wall deposition of Pneumocystis carinii in vitro and in vivo
Bartlett, M. S., Current, W. L., Goheen, M. P., Boylan, C. J., Lee, C., Shaw, M., Queener, S. F., & Smith, J. W. (1996) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.40.8.1811 · Cited by 59
Chiller, T. M., Farrokhshad, K., Brummer, E., & Stevens, D. A. (2001) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/s0732-8893(00)00236-4 · Cited by 56
Self-citationEfficacy of caspofungin combined with amphotericin B against azole-resistant Candida albicans
Hossain, M. (2003) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkg230 · Cited by 54
Osherov, N., May, G. S., Albert, N. D., & Kontoyiannis, D. P. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.8.2462-2469.2002 · Cited by 51
Ju, J. Y., Polhamus, C., Marr, K. A., Holland, S. M., & Bennett, J. E. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.5.1240-1245.2002 · Cited by 48
Chiller, T. M., Farrokhshad, K., Brummer, E., & Stevens, D. A. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.12.3302-3305.2000 · Cited by 39
Self-citationThe parasitic cell wall of Coccidioides immitis
Cole, G. T., & Hung, C.-Y. (2001) · Medical Mycology · doi:10.1080/mmy.39.1.31.40 · Cited by 34
Cited by
Pappas, P. G., Kauffman, C. A., Andes, D. R., Clancy, C. J., Marr, K. A., Ostrosky-Zeichner, L., Reboli, A. C., Schuster, M. G., Vazquez, J. A., Walsh, T. J., et al. (2016) · Clinical Infectious Diseases · doi:10.1093/cid/civ933 · Cited by 4,200
Epidemiology of Invasive Candidiasis: a Persistent Public Health Problem
Pfaller, M. A., & Diekema, D. J. (2007) · Clinical Microbiology Reviews · doi:10.1128/cmr.00029-06 · Cited by 4,174
Pappas, P. G., Kauffman, C. A., Andes, D., Benjamin, D. K., Calandra, T. F., Edwards, J. E., Filler, S. G., Fisher, J. F., Kullberg, B.-J., Zeichner, L. O., et al. (2009) · Clinical Infectious Diseases · doi:10.1086/596757 · Cited by 3,191
Practice Guidelines for the Diagnosis and Management of Skin and Soft-Tissue Infections
Stevens, D. L., Bisno, A. L., Chambers, H. F., Everett, E. D., Dellinger, P., Goldstein, E. J. C., Gorbach, S. L., Hirschmann, J. V., Kaplan, E. L., Montoya, J. G., et al. (2005) · Clinical Infectious Diseases · doi:10.1086/497143 · Cited by 1,602
Self-citationAntifungal activity of silver nanoparticles against Candida spp.
Panáček, A., Kolář, M., Večeřová, R., Prucek, R., Soukupová, J., Kryštof, V., Hamal, P., Zbořil, R., & Kvítek, L. (2009) · Biomaterials · doi:10.1016/j.biomaterials.2009.07.065 · Cited by 964
Metadata
- Authors
- Saravolatz, L. D., Deresinski, S. C., & Stevens, D. A.
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2003-06-01
- Volume
- 36
- Issue
- 11
- Pages
- 1445-1457
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W4210983795
- Cited by
- 293
- References
- 79
- FWCI
- 19.77
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.